| Record ID | marc_western_washington_univ/wwu_bibs.mrc_revrev.mrc:915424002:1951 |
| Source | Western Washington University |
| Download Link | /show-records/marc_western_washington_univ/wwu_bibs.mrc_revrev.mrc:915424002:1951?format=raw |
LEADER: 01951cam 2200421 a 4500
001 ocm78843434
003 OCoLC
005 20071218014502.0
008 061026s2006 dcua b f000 0 eng
010 $a2006475797
035 $a(OCoLC)78843434
040 $aDLC$cDLC$dVVK$dAFQ$dNLM$dBTCTA$dXFF
042 $apcc
043 $an-us---
049 $aXFFD
086 0 $aY 10.2:P 49
100 1 $aAustin, David H.
245 10 $aResearch and development in the pharmaceutical industry /$cCongress of the United States, Congressional Budget Office .
260 $aWashington, D.C. :$bCongress of the United States, Congressional Budget Office,$c2006.
300 $avii, 55 p. :$bill. ;$c28 cm.
440 0 $aCBO study
500 $a"David H. Austin prepared this report ... "-- Pref.
504 $aIncludes bibliographical references (p. [51]-55).
500 $a"October 2006."
505 0 $aIntroduction and summary -- Trends in R&D spending and output of new drugs -- What does lit cost to develop new drug? -- Does federal R&D spending stimulate or substitute for private-sector spending? -- Has the drug industry's innovative performance declined? -- Profitability and R&D investment in the drug industry -- References -- Tables -- Figures -- Boxes.
530 $aAlso available via the World Wide Web.
538 $aMode of access: Internet from the CBO web site. Address as of 10/19/06: http://www.cbo.gov/ftpdocs/76xx/doc7615/10-02-DrugR-D.pdf; current access is available via PURL.
650 0 $aDrugs$xResearch$xGovernment policy$zUnited States.
650 0 $aDrug development$zUnited States.
650 0 $aPharmaceutical industry$xEconomic aspects.
710 1 $aUnited States.$bCongressional Budget Office.
856 41 $zOnline version$uhttp://purl.access.gpo.gov/GPO/LPS75169
907 $a.b21024145$bmulti$c-
902 $a071220
998 $b1$c071218$dm$ea$f-$g0
902 $a071219
902 $adgm
902 $aMARS